BIOMAT Database Logo BIOMAT Database Logo

Design, synthesis and antimycobacterial evaluation of 1-(4-(2-substitutedthiazol-4-yl)phenethyl)-4-(3-(4-substitutedpiperazin-1-yl)alkyl)piperazine hybrid analogues. 2014

Hunsur Nagendra Nagesh, and Amaroju Suresh, and Sirigina Devesh Sathya Sri Sairam, and Dharmarajan Sriram, and Perumal Yogeeswari, and Kondapalli Venkata Gowri Chandra Sekhar
Department of Chemistry, Birla Institute of Technology & Science-Pilani, Hyderabad Campus, R.R. District, 500078, Telangana, India.

A series of twenty six new 1-(4-(2-substitutedthiazol-4-yl)phenethyl)-4-(3-(4-substitutedpiperazin-1-yl)alkyl)piperazine analogues were synthesized by seven steps and evaluated for their anti-tubercular activity against Mycobacterium tuberculosis H37Rv strain. Among the tested compounds, 7j, 7p, and 7r exhibited moderate activity (MIC = 6.25 μg/mL) and compounds 7a, 7f, 7g, 7n and 7v exhibited good activity (MIC = 3.125 μg/mL), while 7h displayed excellent activity (MIC = 1.56 μg/mL) by inhibiting 99% growth of M. tuberculosis H37Rv strain. In addition, all the active compounds were subjected to cytotoxic studies against mouse macrophage (RAW264.7) cell lines and the selectivity index values for most of the compounds is >10 indicating suitability of compounds in an endeavour to attain lead molecule for further drug development.

UI MeSH Term Description Entries
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Hunsur Nagendra Nagesh, and Amaroju Suresh, and Sirigina Devesh Sathya Sri Sairam, and Dharmarajan Sriram, and Perumal Yogeeswari, and Kondapalli Venkata Gowri Chandra Sekhar
Discovery of potent antitubercular agents: Design, synthesis and biological evaluation of 4-(3-(4-substitutedpiperazin-1-yl)-quinoxalin-2-yl)-naphthalen-1-ol analogues.
August 2022, Toxicology in vitro : an international journal published in association with BIBRA,
Hunsur Nagendra Nagesh, and Amaroju Suresh, and Sirigina Devesh Sathya Sri Sairam, and Dharmarajan Sriram, and Perumal Yogeeswari, and Kondapalli Venkata Gowri Chandra Sekhar
Design, synthesis and evaluation of 6-(4-((substituted-1H-1,2,3-triazol-4-yl)methyl)piperazin-1-yl)phenanthridine analogues as antimycobacterial agents.
December 2013, Bioorganic & medicinal chemistry letters,
Hunsur Nagendra Nagesh, and Amaroju Suresh, and Sirigina Devesh Sathya Sri Sairam, and Dharmarajan Sriram, and Perumal Yogeeswari, and Kondapalli Venkata Gowri Chandra Sekhar
Synthesis and preliminary pharmacological evaluation of N-2-(4-(4-(2-substitutedthiazol-4-yl) piperazin-1-yl)-2-oxoethyl)acetamides as novel atypical antipsychotic agents.
December 2008, Bioorganic & medicinal chemistry letters,
Hunsur Nagendra Nagesh, and Amaroju Suresh, and Sirigina Devesh Sathya Sri Sairam, and Dharmarajan Sriram, and Perumal Yogeeswari, and Kondapalli Venkata Gowri Chandra Sekhar
[Preparation and physico-chemical properties of alkyl esters of 2-, 3-, 4-(2-hydroxy-3-[4-diphenylmethyl) piperazine-1-yl] propoxy) phenylcarbamide].
November 2002, Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti,
Hunsur Nagendra Nagesh, and Amaroju Suresh, and Sirigina Devesh Sathya Sri Sairam, and Dharmarajan Sriram, and Perumal Yogeeswari, and Kondapalli Venkata Gowri Chandra Sekhar
Synthesis, antimicrobial and antimycobacterial evaluation of [2-(substituted phenyl)-imidazol-1-yl]-pyridin-3-yl-methanones.
October 2011, Journal of enzyme inhibition and medicinal chemistry,
Hunsur Nagendra Nagesh, and Amaroju Suresh, and Sirigina Devesh Sathya Sri Sairam, and Dharmarajan Sriram, and Perumal Yogeeswari, and Kondapalli Venkata Gowri Chandra Sekhar
Synthesis and cytotoxic activity of novel 3-methyl-1-[(4-substitutedpiperazin-1-yl)methyl]-1H-indole derivatives.
August 2012, Arzneimittel-Forschung,
Hunsur Nagendra Nagesh, and Amaroju Suresh, and Sirigina Devesh Sathya Sri Sairam, and Dharmarajan Sriram, and Perumal Yogeeswari, and Kondapalli Venkata Gowri Chandra Sekhar
[Design, synthesis and vasorelaxant activity of R, S-1-(substituted phenyl)-4-[3-(naphtha-1-yl-oxy)-2-hydroxypropyl]-piperazine derivatives].
July 2007, Yao xue xue bao = Acta pharmaceutica Sinica,
Hunsur Nagendra Nagesh, and Amaroju Suresh, and Sirigina Devesh Sathya Sri Sairam, and Dharmarajan Sriram, and Perumal Yogeeswari, and Kondapalli Venkata Gowri Chandra Sekhar
Design, synthesis and antimycobacterial activity of various 3-(4-(substitutedsulfonyl)piperazin-1-yl)benzo[d]isoxazole derivatives.
November 2014, European journal of medicinal chemistry,
Hunsur Nagendra Nagesh, and Amaroju Suresh, and Sirigina Devesh Sathya Sri Sairam, and Dharmarajan Sriram, and Perumal Yogeeswari, and Kondapalli Venkata Gowri Chandra Sekhar
Synthesis and antimycobacterial activity of some N1-[1-[3-aryl-1-(pyridin-2-, 3-, or 4-yl)-3-oxo]propyl]-2- pyridinecarboxamidrazones.
January 1999, Farmaco (Societa chimica italiana : 1989),
Hunsur Nagendra Nagesh, and Amaroju Suresh, and Sirigina Devesh Sathya Sri Sairam, and Dharmarajan Sriram, and Perumal Yogeeswari, and Kondapalli Venkata Gowri Chandra Sekhar
Synthesis of 3'-(4-nitroimidazol-1-yl)-2',3'-dideoxynucleosides of pyrimidine analogues and their biological evaluation against HIV.
December 1990, Archiv der Pharmazie,
Copied contents to your clipboard!